Provided by Tiger Fintech (Singapore) Pte. Ltd.

60 degrees pharmaceuticals, Inc.

1.89
+0.14008.00%
Post-market: 1.80-0.0900-4.76%18:11 EDT
Volume:25.64K
Turnover:46.67K
Market Cap:2.78M
PE:-0.06
High:1.91
Open:1.74
Low:1.71
Close:1.75
Loading ...

Company Profile

Company Name:
60 degrees pharmaceuticals, Inc.
Exchange:
NASDAQ
Establishment Date:
2010
Employees:
3
Office Location:
1025 Connecticut Avenue NW,Suite 1000,Washington,District Of Columbia,United States
Zip Code:
20036
Fax:
- -
Introduction:
60 Degrees Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases in the United States. The company offers Arakoda for malaria preventative treatment. It also engages in the development of Tafenoquine (Arakoda regimen) that is in Phase IIb clinical trial for COVID-19 indications; Tafenoquine, which is in phase IIA clinical trials for babesiosis, fungal pneumonias, and candidiasis disease; and Celgosivir for respiratory viruses and dengue. 60 Degrees Pharmaceuticals, Inc. was founded in 2010 and is based in Washington, District Of Columbia.

Directors

Name
Position
Geoffrey Dow
Chief Executive Officer, President and Director,Chairman

Shareholders

Name
Position
Geoffrey Dow
Chief Executive Officer, President and Director,Chairman
Tyrone Miller
Chief Financial Officer
Bryan Smith
Chief Medical Officer